Geert-Jan Boons Selected Research

Cytidine Monophosphate N-Acetylneuraminic Acid

1/2021

N-Glycolylneuraminic Acid in Animal Models for Human Influenza A Virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Geert-Jan Boons Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 10/2003
15	Infections 02/2022 - 09/2007
5	Human Influenza (Influenza) 12/2022 - 08/2016
4	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2012
3	Mucopolysaccharidoses 10/2022 - 01/2012
3	Muscular Dystrophies (Muscular Dystrophy) 10/2017 - 12/2013
2	Anthrax 01/2020 - 12/2006
2	Lymphoma (Lymphomas) 07/2014 - 11/2010
2	Pathologic Processes 04/2014 - 12/2009
2	Inhalation anthrax 05/2011 - 06/2009
2	Meningococcal Meningitis 07/2008 - 01/2008
2	Bacterial Infections (Bacterial Infection) 09/2007 - 10/2002
1	Necrosis 02/2022
1	Systemic Vasculitis 02/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Thrombocytopenia (Thrombopenia) 12/2021
1	Polyneuropathies (Polyneuropathy) 11/2020
1	Guillain-Barre Syndrome 11/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Cutaneous anthrax 01/2020
1	Influenza in Birds (Avian Flu) 01/2020
1	Vesicular Stomatitis 12/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2019
1	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2018
1	Acute Erythroblastic Leukemia (Erythroleukemia) 02/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 09/2011
1	Hypoxia (Hypoxemia) 03/2011

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 01/2022 - 10/2003
10	AntibodiesIBA 01/2022 - 10/2007
10	Polysaccharides (Glycans)IBA 01/2022 - 07/2008
10	VaccinesIBA 01/2018 - 09/2005
9	CarbohydratesIBA 01/2022 - 09/2005
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2007
7	GlycopeptidesIBA 01/2017 - 09/2005
6	LigandsIBA 01/2022 - 12/2009
5	OligosaccharidesIBA 11/2020 - 12/2006
5	EnzymesIBA 01/2020 - 01/2009
5	EpitopesIBA 01/2020 - 10/2007
5	Immunoglobulin G (IgG)IBA 01/2018 - 10/2007
5	Carrier Proteins (Binding Protein)IBA 04/2014 - 07/2004
4	Sialic AcidsIBA 12/2022 - 10/2018
4	Dystroglycans (Dystroglycan)IBA 01/2022 - 12/2013
4	Heparitin Sulfate (Heparan Sulfate)IBA 01/2018 - 12/2009
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021 - 07/2008
3	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 08/2016
3	Tn antigenIBA 01/2020 - 09/2005
3	Glycoproteins (Glycoprotein)IBA 01/2019 - 09/2009
3	Mucin-1 (CA 15-3 Antigen)IBA 01/2017 - 01/2012
3	Peptides (Polypeptides)IBA 01/2017 - 01/2016
3	Cancer VaccinesIBA 07/2014 - 10/2007
2	ArylsulfatasesIBA 10/2022 - 01/2020
2	GangliosidesIBA 01/2022 - 11/2020
2	SialyltransferasesIBA 01/2022 - 02/2016
2	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 01/2015
2	anthrax toxin (anthrax lethal factor)IBA 01/2020 - 05/2011
2	GlycosaminoglycansIBA 01/2020 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 01/2012
2	Pharmaceutical PreparationsIBA 01/2016 - 05/2003
2	Biological ProductsIBA 04/2014 - 12/2009
2	GlycoconjugatesIBA 10/2013 - 01/2013
2	Peptide TIBA 02/2009 - 10/2007
2	Synthetic Vaccines (Recombinant Vaccines)IBA 02/2009 - 10/2007
2	Lipid AIBA 01/2008 - 05/2003
2	LipopolysaccharidesIBA 01/2008 - 10/2002
1	Viral AntigensIBA 02/2022
1	Mannose (D-Mannose)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Cell ExtractsIBA 01/2022
1	DisaccharidesIBA 01/2022
1	ParaffinIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	Neuraminidase (Sialidase)IBA 01/2022
1	Laminin (Merosin)IBA 01/2022
1	AnticoagulantsIBA 12/2021
1	Platelet Factor 4IBA 12/2021
1	Cytidine Monophosphate N-Acetylneuraminic AcidIBA 01/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2020
1	Glucuronic Acid (Glucuronate)IBA 01/2020
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Forssman glycolipid (GL-5)IBA 01/2019
1	N-sulfoglucosamine sulfohydrolase (sulfamidase)IBA 01/2018
1	TransferasesIBA 12/2016
1	Amino Acids FDA Link 03/2016
1	SialoglycoproteinsIBA 02/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Antithrombin IIIIBA 01/2015
1	poly-N-acetyllactosamineIBA 10/2014
1	Therapeutic UsesIBA 07/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2014
1	ActininIBA 09/2011
1	TrisaccharidesIBA 05/2011
1	4,6- dideoxy- 4- (3- hydroxy- 3- methylbutanamido)- 2- O- methylglucopyranoseIBA 05/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 03/2011
1	Ligases (Synthetase)IBA 03/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 07/2007
2	Immunotherapy 09/2009 - 02/2009
1	Lasers (Laser) 01/2022